The Association for Accessible Medicines and the National Association of Chain Drug Stores are lobbying Congress and the White House for a change in the Centers for Medicare and Medicaid Services’ policy on reimbursement for biosimilar medicines
The retail pharmacy world currently awaits legislative action that can help retain access to chronic pain treatments for patients that need it, while curbing the potential for abuse by those that do not.
The spike in hospitalizations related to influenza-like illnesses has created spot shortages in anti-viral medicines and flu tests and has exasperated the supply issue with IV saline bags, agencies report.
The Association for Accessible Medicines CEO, Chip Davis, discusses the savings that generics bring to the healthcare system and how competition can help keep the savings coming.
In this special report, DSN takes a look at the collaborative solutions the industry is undertaking to keep patients safe as deaths from opioid abuse and misuse continue to rise.
The company has begun dispensing preservative-free dorzolamide and preservative-free dorzolamide/timolol — the latter of which is a compounded version of a combination marketed as Cosopt and Cosopt PF.
